CD8A and neoplasm: CD8+ cells and macrophages can work synergistically to exert anti-tumor mediated effects, supporting a rationale for possible combination immunotherapy treatments, such as modulation of macrophage phenotypes together with checkpoint inhibitors to combat T cell exhaustion [45].